Dermatology Pipeline Updates: Plaque Psoriasis, Atopic Dermatitis and More
The current dermatology pipeline includes a wide range of medication classes, from Janus kinase (JAK) inhibitors to tumor necrosis factor inhibitors, to phototherapeutics. At the 2023 American Society of Health-System Pharmacists (ASHP) Summer Meetings and Exhibition,1 Courtney Queen, PharmD, CSP, of the University of Kentucky Specialty Pharmacy and Infusion Services in Lexington, Kentucky, shared a quick snapshot of some of that pipeline. Although only 4 conditions were covered—chosen due to the high number of agents in the pipeline—Queen noted that “there are so many more [drugs] we could talk about.”
Reference
1. Rim M, Queen C, Huffmyer M. Specialty pharmacy pipeline updates II: Emerging therapies for complex conditions. Presented at: American Society of Health-System Pharmacists Summer Meetings and Exhibition; June 10-14, 2023; Baltimore, MD.
Q&A: Pharmacist-Led Diabetes Management Transforms Patient Care and Clinical Outcomes
June 28th 2025An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.
